rs41545520

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000429656.1(ENSG00000227766):​n.580C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 9 hom., cov: 18)
Exomes 𝑓: 0.070 ( 497 hom. )
Failed GnomAD Quality Control

Consequence

ENSG00000227766
ENST00000429656.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.96

Publications

6 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124901298XR_007059541.1 linkn.813+2293C>T intron_variant Intron 1 of 2
HLA-ANM_002116.8 linkc.-66G>A upstream_gene_variant ENST00000376809.10 NP_002107.3 P04439-1B1PKY1B2R7U3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-AENST00000376809.10 linkc.-66G>A upstream_gene_variant 6 NM_002116.8 ENSP00000366005.5 P04439-1

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
13395
AN:
116976
Hom.:
9
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.0106
Gnomad AMR
AF:
0.160
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.158
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.0261
Gnomad MID
AF:
0.151
Gnomad NFE
AF:
0.0586
Gnomad OTH
AF:
0.132
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0697
AC:
50473
AN:
724586
Hom.:
497
Cov.:
10
AF XY:
0.0711
AC XY:
26329
AN XY:
370134
show subpopulations
African (AFR)
AF:
0.201
AC:
3215
AN:
16020
American (AMR)
AF:
0.202
AC:
3705
AN:
18358
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
1727
AN:
12852
East Asian (EAS)
AF:
0.223
AC:
5215
AN:
23412
South Asian (SAS)
AF:
0.131
AC:
6815
AN:
52026
European-Finnish (FIN)
AF:
0.0330
AC:
1086
AN:
32866
Middle Eastern (MID)
AF:
0.131
AC:
406
AN:
3092
European-Non Finnish (NFE)
AF:
0.0474
AC:
25274
AN:
533494
Other (OTH)
AF:
0.0933
AC:
3030
AN:
32466
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1621
3242
4862
6483
8104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.115
AC:
13425
AN:
117062
Hom.:
9
Cov.:
18
AF XY:
0.115
AC XY:
6457
AN XY:
56282
show subpopulations
African (AFR)
AF:
0.211
AC:
6600
AN:
31332
American (AMR)
AF:
0.160
AC:
1685
AN:
10528
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
352
AN:
2814
East Asian (EAS)
AF:
0.159
AC:
611
AN:
3852
South Asian (SAS)
AF:
0.143
AC:
532
AN:
3708
European-Finnish (FIN)
AF:
0.0261
AC:
199
AN:
7636
Middle Eastern (MID)
AF:
0.151
AC:
36
AN:
238
European-Non Finnish (NFE)
AF:
0.0586
AC:
3204
AN:
54686
Other (OTH)
AF:
0.131
AC:
198
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.426
Heterozygous variant carriers
0
414
827
1241
1654
2068
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00359
Hom.:
46

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
5.5
DANN
Benign
0.84
PhyloP100
-5.0
PromoterAI
-0.30
Neutral
Mutation Taster
=294/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41545520; hg19: chr6-29910265; API